Mindbio will analyze your voice, detect intoxication

Executive Summary

• Mindbio Therapeutics Corp. is targeting the global digital health diagnostics market with a world-first AI-powered speech analytics technology designed to detect drug and alcohol intoxication.
• The technology utilizes sophisticated machine learning models trained on clinical trial data to analyze voice biomarkers, predicting intoxication and estimating blood alcohol concentration with high accuracy.
• The company is currently showcasing the technology in the United States and plans to expand its algorithms to detect other prohibited drugs, with potential applications in workplace safety, law enforcement, and mental health.

Key Details

• Core Technology: AI-powered speech analytics that analyzes voice data to predict drug and alcohol intoxication.
• Data Foundation: The AI model is trained on over 50 million data points derived from years of clinical trials.
• Capabilities:
  • Reliable prediction of intoxication with hallucinogens and alcohol.
  • Estimation of actual blood alcohol concentration (BAC) levels.
  • Proprietary algorithms developed for remarkable accuracy.
• Target Markets:
  • Workplace environments requiring mandated testing (mining, aviation, construction).
  • High-volume testing scenarios where specialized equipment is costly or time-consuming.
  • Call centers, mental health sectors, and law enforcement.
• Future Plans:
  • Expansion of algorithms to detect other prohibited drugs that are difficult to detect at scale.
  • Development of an enterprise version and new platform-level technology for broader health prediction.
  • Upcoming announcements regarding new products, markets, and commercial applications.
• CEO Commentary: Justin Hanka highlighted the significant opportunity in the digital health diagnostics market and Mindbio's first-mover advantage in speech analytics for intoxication detection.

Notable Quotes

• "The digital health diagnostics market represents a significant opportunity for Mindbio to leverage its diagnostics technology with a first mover advantage in speech analytics for drug and alcohol intoxication detection." — Justin Hanka, CEO